Cargando…
Real-World Outcomes of Direct-Acting Antiviral Treatment and Retreatment in United Kingdom–Based Patients Infected With Hepatitis C Virus Genotypes/Subtypes Endemic in Africa( )
BACKGROUND: Chronic hepatitis C virus (HCV) infection affects 71 million individuals, mostly residing in low- and middle-income countries (LMICs). Direct-acting antivirals (DAAs) give high rates of sustained virological response (SVR) in high-income countries where a restricted range of HCV genotype...
Autores principales: | Aranday-Cortes, Elihu, McClure, C Patrick, Davis, Christopher, Irving, William L, Adeboyejo, Kazeem, Tong, Lily, da Silva Filipe, Ana, Sreenu, Vattipally, Agarwal, Kosh, Mutimer, David, Stone, Benjamin, Cramp, Matthew E, Thomson, Emma C, Ball, Jonathan K, McLauchlan, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492310/ https://www.ncbi.nlm.nih.gov/pubmed/33668068 http://dx.doi.org/10.1093/infdis/jiab110 |
Ejemplares similares
-
The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolutionary Kinetics and Selective Force Analysis
por: Xu, Ru, et al.
Publicado: (2022) -
Hepatitis C subtyping assay failure in UK patients born in sub‐Saharan Africa: Implications for global treatment and elimination
por: Adeboyejo, Kazeem, et al.
Publicado: (2022) -
The evolutionary dynamics and epidemiological history of hepatitis C virus genotype 6, including unique strains from the Li community of Hainan Island, China
por: Xu, Ru, et al.
Publicado: (2022) -
Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
por: Ansari, M Azim, et al.
Publicado: (2019) -
A Human and Rhesus Macaque Interferon-Stimulated Gene Screen Shows That Over-Expression of ARHGEF3/XPLN Inhibits Replication of Hepatitis C Virus and Other Flavivirids
por: Bamford, Connor G. G., et al.
Publicado: (2022)